Fountainhead AM’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$523K Buy
436
+110
+34% +$112K 0.39% 51
2026
Q1
$300K Buy
326
+280
+609% +$284K 0.27% 66
2025
Q4
$49.5K Sell
46
-862
-95% -$824K 0.07% 103
2025
Q3
$693K Buy
908
+66
+8% +$49.1K 0.09% 94
2025
Q2
$657K Sell
842
-1
-0.1% -$777 0.1% 89
2025
Q1
$696K Buy
843
+51
+6% +$42.4K 0.11% 67
2024
Q4
$611K Buy
792
+141
+22% +$117K 0.11% 72
2024
Q3
$577K Sell
651
-40
-6% -$36K 0.12% 65
2024
Q2
$626K Buy
+691
New +$553K 0.15% 57

Other funds holding LLY

Fountainhead AM's LLY Position: Q2 2026 in Review

Fountainhead AM increased its Eli Lilly (LLY) stake by 34% in Q2 2026, buying an estimated $112K and bringing the position to 436 shares worth $523K. The position accounts for 0.39% of the portfolio, ranked #51.

Fountainhead AM first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. The position peaked at $696K in Q1 2025. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Fountainhead AM held 436 shares of Eli Lilly worth $523K as of Q2 2026.
  • Fountainhead AM bought 110 Eli Lilly shares in Q2 2026, an estimated $112K.
  • Eli Lilly made up 0.39% of Fountainhead AM's portfolio in Q2 2026, its #51 holding.
  • Fountainhead AM first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
  • Fountainhead AM's Eli Lilly position peaked at $696K in Q1 2025.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Fountainhead AM's 13F filing for Q2 2026, filed 3 Aug 2026.